Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
398 Leser
Artikel bewerten:
(2)

Dr. Patrick F. Doherty Recognized for Three Decades of Leadership in Advanced Neurosurgery and Patient Centered Care in Connecticut

Three decades of surgical excellence, academic leadership at Yale, and nationally recognized patient outcomes define Dr. Patrick F. Doherty's impact on neurosurgery and spine care in Connecticut

NEW LONDON, CONNECTICUT / ACCESS Newswire / February 12, 2026 / Clinical Leadership in Neurosurgery and Spine Care

Dr. Patrick F. Doherty, MD, a board-certified neurosurgeon with more than 30 years of clinical and academic experience, continues to be recognized as a leading authority in neurosurgery and advanced spine care in Connecticut. Based in New London, Dr. Doherty serves as Chief of Neurosurgery at Lawrence + Memorial Hospital and leads the hospital's Spine Care Center of Excellence. He also holds the position of Associate Professor of Clinical Neurosurgery at Yale School of Medicine.

Academic Background and Surgical Training

Dr. Doherty completed his undergraduate education at Johns Hopkins University before earning his Doctor of Medicine from Rutgers Medical School. His postgraduate training included a rigorous neurosurgical residency at the University of Maryland and Shock Trauma, where he developed extensive expertise in both cranial and spinal surgery. He achieved board certification in neurological surgery in 2002, with recertification in 2012, reflecting an ongoing commitment to professional excellence and continuing education.

Specialization in Advanced and Minimally Invasive Neurosurgery

Dr. Doherty's clinical practice focuses on the treatment of complex neurological and spinal conditions, including herniated discs, spinal tumors, traumatic brain injuries, blood clots in the brain, and severe cranial trauma. He is recognized for his leadership in minimally invasive and robotic-assisted spine surgery, including the use of ExcelsiusGPS, enabling greater surgical precision, improved outcomes, and reduced recovery times for patients.

Hospital Governance and Quality Improvement Leadership

Beyond clinical care, Dr. Doherty plays a key role in hospital leadership and quality initiatives. He has chaired the Surgical Services Governance Committee and actively participates in patient safety programs, spine collaboratives, and surgical unit safety initiatives. His work supports continuous improvement in surgical outcomes, operational efficiency, and patient safety standards.

Patient Centered Care Philosophy

Dr. Doherty is widely known for his patient-focused approach to care. He emphasizes education, transparency, and clear communication, often using visual aids such as MRI imaging and anatomical models to help patients understand their diagnoses and treatment options. His care philosophy integrates rehabilitation, lifestyle modification, and stress management as part of comprehensive recovery planning.

Awards, Honors, and Professional Recognition

Dr. Doherty has been named a Connecticut Top Doctor every year since 2011, reflecting sustained peer recognition and clinical excellence. He is a Fellow of the American College of Surgeons and the American Association of Neurological Surgeons. He has also received the Outstanding Patient Experience Award in 2023, 2024, and 2025. Lawrence + Memorial Hospital has been recognized as one of America's 250 Best Hospitals, placing it among the top five percent nationally for clinical quality.

Academic Contributions and Media Presence

Dr. Doherty regularly lectures at national and international conferences on degenerative spine care, minimally invasive surgery, and emerging neurosurgical technologies. He has contributed to peer-reviewed research on spinal cord stimulation, pain management, and surgical learning curves. His expertise is frequently featured across hospital platforms, professional publications, and national media outlets.

Reputation and Patient Trust

There are no reported disciplinary actions, malpractice settlements, or board sanctions associated with Dr. Doherty. Patient ratings across major review platforms consistently exceed 4.5 out of 5, with testimonials highlighting his surgical skill, compassionate communication style, and commitment to follow-up care.

Media Availability

Dr. Patrick F. Doherty is available for expert commentary, interviews, and educational discussions through Trustpoint Xposure.

Jack Smith
Media Director
Trustpoint Xposure
contact@trustpointxposure.com

SOURCE: Dr. Patrick F. Doherty



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/dr.-patrick-f.-doherty-recognized-for-three-decades-of-leadership-in-1135905

© 2026 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.